10 April 2014 - Deborah Wilkes
Archived
Merck & Co is seeking to switch Singulair (montelukast) from prescription-only to OTC status in the US as an allergy remedy but not an asthma treatment.
New to OTCToolbox?
This is available as part of an Annual Subscription to the OTCToolbox website.